Stockscreener 앱 받기
19.07
9.85%
1.71
전일 마감가:
$17.36
열려 있는:
$17.585
하루 거래량:
8.31M
Relative Volume:
3.97
시가총액:
$2.71B
수익:
-
순이익/손실:
$-45.61M
주가수익비율:
-58.95
EPS:
-0.3235
순현금흐름:
$-45.40M
1주 성능:
+6.89%
1개월 성능:
+16.49%
6개월 성능:
+81.97%
1년 성능:
+178.80%
1일 변동 폭
$17.23
$20.22
1주일 범위
$16.24
$20.22
52주 변동 폭
$6.55
$20.22
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
Compare TRVI vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
19.07 | 2.46B | 0 | -45.61M | -45.40M | -0.3235 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 개시 | Leerink Partners | Outperform |
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
TRVI Jumps As Trevi Therapeutics Extends Bullish Run - timothysykes.com
TRVI Surges As Trevi Therapeutics Draws Aggressive Buyers - StocksToTrade
symbol__ Stock Quote Price and Forecast - CNN
Trevi Therapeutics (NASDAQ:TRVI) Hits New 1-Year HighHere's Why - MarketBeat
Trevi Therapeutics (TRVI) Soars as Haduvio Taps Into $15B Addressable Market - Yahoo Finance
Why Trevi Therapeutics (TRVI) Stock Is Up Today - Quiver Quantitative
Trevi climbs as GSK drops chronic cough therapy (TRVI:NASDAQ) - Seeking Alpha
TRVI Stock Firms Up As Haduvio Story Hits Center Stage - StocksToTrade
Trevi Therapeutics (TRVI) Sees Significant Price Increase - GuruFocus
Trevi Therapeutics (NASDAQ:TRVI) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Trevi Therapeutics Shares Surge 13% as Biopharma Investors Cheer Cough Drug Data at London Conference - International Business Times Australia
Stock Traders Buy Large Volume of Trevi Therapeutics Call Options (NASDAQ:TRVI) - MarketBeat
Trevi Therapeutics (NASDAQ:TRVI) Trading Up 7.4%What's Next? - MarketBeat
Candriam S.C.A. Purchases Shares of 773,620 Trevi Therapeutics, Inc. $TRVI - MarketBeat
Trevi Therapeutics (TRVI) Slips 3% as Shares Approach Key Support at $16.95Earnings Quality Factor - dars.gov.et
Trevi Therapeutics Targets Refractory Chronic Cough With Fresh Phase 2 Trial - TipRanks
Trevi Therapeutics Inc. (TRVI) Q1 2026 Earnings: EPS Miss and No Revenue Highlight the Challenges of a Pre-Commercial BiotechEarnings Expansion Phase - DonanımHaber
SG Americas Securities LLC Decreases Stock Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
TRVi stock stays tied to Trevi Therapeutics' clinical outlook - ad-hoc-news.de
Price to earnings forward of Trevi Therapeutics, Inc. – NASDAQ:TRVI - TradingView
Price to sales forward of Trevi Therapeutics, Inc. – NASDAQ:TRVI - TradingView
Price to book forward of Trevi Therapeutics, Inc. – NASDAQ:TRVI - TradingView
Enterprise value to revenue forward of Trevi Therapeutics, Inc. – NASDAQ:TRVI - TradingView
Price to earnings forward of Trevi Therapeutics, Inc. – BOATS:TRVI - TradingView
Trevi Therapeutics stock hits all-time high at 19.33 USD By Investing.com - Investing.com South Africa
Trevi Therapeutics stock hits all-time high at 19.33 USD - Investing.com
$Trevi Therapeutics (TRVI.US)$ keep squeezing baby - Moomoo
Should Trevi’s Multi‑Index Russell Exit Reshape How Haduvio Drives the Trevi Therapeutics (TRVI) Story? - simplywall.st
Trevi Therapeutics, Inc.(NasdaqGM: TRVI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Trevi Therapeutics, Inc.(NasdaqGM: TRVI) dropped from Russell Microcap Index - marketscreener.com
Trevi Therapeutics, Inc.(NasdaqGM: TRVI) dropped from Russell 3000E Index - marketscreener.com
Trevi Therapeutics, Inc.(NasdaqGM:TRVI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
A Quick Look at Today's Ratings for Trevi Therapeutics(TRVI.US), With a Forecast Between $18 to $23 - Moomoo
Trevi Therapeutics stock hits all-time high at 18.17 USD By Investing.com - Investing.com Australia
Trevi Therapeutics stock hits all-time high at 18.17 USD - Investing.com
Trevi Therapeutics, Inc. Actuals & Estimates (NASDAQ:TRVI) - TradingView
TRVI Forecast — Price Target — Prediction for 2027 - TradingView
Trevi Therapeutics Inc (TRVI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
$Trevi Therapeutics (TRVI.US)$ finally you are getting squeezed - Moomoo
Trevi Therapeutics Inc (TRVI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Trevi Therapeutics Inc (TRVI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Trevi Therapeutics Inc (TRVI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Trevi Therapeutics Inc (TRVI) Institutional Confidence - TradingKey
Trevi Therapeutics Inc (TRVI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Trevi Therapeutics Inc (TRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Trevi Therapeutics stock hits all-time high at 16.13 USD By Investing.com - Investing.com Nigeria
Trevi Therapeutics Inc (TRVI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Trevi Therapeutics Inc (TRVI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Trevi Therapeutics Announces Upcoming June and July Event Schedule - GlobeNewswire
Trevi Therapeutics Slides As Hot Biotech Rally Cools - TipRanks
Trevi Therapeutics (TRVI) Surges 5.05% as Momentum Builds Near ResistanceBox Spread - dars.gov.et
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
2.11%
자본화:
|
볼륨(24시간):